Literature DB >> 23523693

The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.

Ann K Shinn1, Stephan Heckers, Dost Öngür.   

Abstract

The presence of a single first-rank auditory hallucination (FRAH) or bizarre delusion (BD) is sufficient to satisfy the symptom criterion for a DSM-IV-TR diagnosis of schizophrenia. We queried two independent databases to investigate how prevalent FRAH and BD are in schizophrenia spectrum disorders and whether the diagnosis depends on them. FRAH was common in both datasets (42.2% and 55.2%) and BD was present in the majority of patients (62.5% and 69.7%). However, FRAH and BD rarely determined the diagnosis. In the first database, we found only seven cases among 325 patients (2.1%) and in the second database we found only one case among 201 patients (0.5%) who were diagnosed based on FRAH or BD alone. Among patients with FRAH, 96% had delusions, 14-42% had negative symptoms, 15-21% had disorganized or catatonic behavior, and 20-23% had disorganized speech. Among patients with BD, 88-99% had hallucinations, 17-49% had negative symptoms, 20-27% had disorganized or catatonic behavior, and 21-25% had disorganized speech. We conclude that FRAH and BD are common features of schizophrenia spectrum disorders, typically occur in the context of other psychotic symptoms, and very rarely constitute the sole symptom criterion for a DSM-IV-TR diagnosis of schizophrenia.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23523693      PMCID: PMC3667611          DOI: 10.1016/j.schres.2013.02.040

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  DSM-5 status of psychotic disorders: 1 year prepublication.

Authors:  Rajiv Tandon; William T Carpenter
Journal:  Schizophr Bull       Date:  2012-04-13       Impact factor: 9.306

Review 2.  What is bizarre in bizarre delusions? A critical review.

Authors:  M Cermolacce; L Sass; J Parnas
Journal:  Schizophr Bull       Date:  2010-02-08       Impact factor: 9.306

Review 3.  The nosology of schizophrenia: toward DSM-5 and ICD-11.

Authors:  Rajiv Tandon
Journal:  Psychiatr Clin North Am       Date:  2012-07-20

4.  Dimensions of delusional experience.

Authors:  K S Kendler; W M Glazer; H Morgenstern
Journal:  Am J Psychiatry       Date:  1983-04       Impact factor: 18.112

5.  Auditory hallucinations in a cross-diagnostic sample of psychotic disorder patients: a descriptive, cross-sectional study.

Authors:  Ann K Shinn; Danielle Pfaff; Sarah Young; Kathryn E Lewandowski; Bruce M Cohen; Dost Öngür
Journal:  Compr Psychiatry       Date:  2011-12-22       Impact factor: 3.735

6.  Discriminating symptoms in schizophrenia. A report from the international pilot study of schizophrenia.

Authors:  J Wing; J Nixon
Journal:  Arch Gen Psychiatry       Date:  1975-07

7.  Thalamocortical dysconnectivity in schizophrenia.

Authors:  Neil D Woodward; Haleh Karbasforoushan; Stephan Heckers
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

8.  First rank symptoms and diagnosis of schizophrenia in developing countries.

Authors:  S H Ahmed; S Naeem
Journal:  Psychopathology       Date:  1984       Impact factor: 1.944

9.  A study of Schneider's first-rank symptoms of schizophrenia in Nigerian patients.

Authors:  O Gureje; E A Bamgboye
Journal:  Br J Psychiatry       Date:  1987-06       Impact factor: 9.319

Review 10.  The diagnostic status of first-rank symptoms.

Authors:  Julie Nordgaard; Sidse M Arnfred; Peter Handest; Josef Parnas
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

View more
  3 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

3.  Aberrant cerebellar connectivity in motor and association networks in schizophrenia.

Authors:  Ann K Shinn; Justin T Baker; Kathryn E Lewandowski; Dost Öngür; Bruce M Cohen
Journal:  Front Hum Neurosci       Date:  2015-03-18       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.